Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / January / InfluenzaScreening Could a TasteBased Sensor Play a Role
Sensors Clinical Translational Science

Influenza Screening: Could a Taste-Based Sensor Play a Role?

Selective methylation of N-acetylneuraminic acid enabled a taste-releasing sensor to distinguish influenza neuraminidase from bacterial enzymes 

By Kathryn Wighton 01/13/2026 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders

Share

Top Institutions in Infectious Disease Diagnostics

Institutions leading in infectious disease diagnostics and sensor technology typically combine expertise in virology, chemical biology, and clinical translational research to develop innovative diagnostic tools. Their methodologies often include molecular engineering of biosensors, clinical sample validation, and integration of patient-centered outcomes.

  • #1

    Massachusetts Institute of Technology (MIT)

    Cambridge, MA

    MIT is a leader in biosensor development and chemical engineering, with strong translational research programs that integrate molecular sensor design and clinical validation, making it a pioneer in rapid diagnostic technologies for infectious diseases.

    Key Differentiators

    • Infectious Disease Diagnostics
    • Chemical Biology
    • Biomedical Engineering
  • #2

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins has a world-renowned infectious diseases division and extensive experience in clinical virology and biomarker discovery, supporting development and clinical testing of novel influenza diagnostics.

    Key Differentiators

    • Infectious Diseases
    • Clinical Virology
    • Translational Medicine
  • #3

    University of California, San Francisco (UCSF)

    San Francisco, CA

    UCSF combines clinical infectious disease expertise with innovation in diagnostic technologies, emphasizing patient-centered outcomes and rapid testing approaches for respiratory viruses including influenza.

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Biomedical Innovation
  • #4

    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    The CDC leads national influenza surveillance and has expertise in viral diagnostics development and validation, providing critical data on neuraminidase activity and influenza viral loads in clinical samples.

    Key Differentiators

    • Public Health
    • Virology
    • Diagnostic Development
  • #5

    Stanford University

    Stanford, CA

    Stanford’s interdisciplinary approach integrates chemical biology and engineering to develop novel biosensors and diagnostic platforms, with a focus on rapid detection of infectious agents including influenza.

    Key Differentiators

    • Biomedical Engineering
    • Infectious Diseases
    • Chemical Biology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

False

Advertisement

Recommended

False

Related Content

Meeting Mpox Where It’s At
Sensors
Meeting Mpox Where It’s At

December 17, 2024

1 min read

New optical biosensor offers mpox virus detection in 20 minutes

Dropletronics
Sensors
Dropletronics

December 31, 2024

1 min read

Biocompatible electronic devices open up new possibilities for in situ disease detection

Molecularly Imprinted Polymers: The Future of Smart and Sustainable Sensing
Sensors
Molecularly Imprinted Polymers: The Future of Smart and Sustainable Sensing

October 14, 2024

4 min read

Unlocking the potential of synthetic receptors for precise, eco-friendly diagnostics and environmental monitoring – paving the way for next-gen sensor technology

Hydrogen Boon
Sensors
Hydrogen Boon

November 12, 2024

1 min read

Tunable diode laser absorption spectroscopy (TDLAS) technique offers high-sensitivity, calibration-free hydrogen gas detection

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.